122 related articles for article (PubMed ID: 6288701)
21. Binding of fibrinogen molecules to pig platelets and their membranes.
Cierniewski CS; Kowalska MA; Krajewski T; Janiak A
Biochim Biophys Acta; 1982 Feb; 714(3):543-8. PubMed ID: 6277391
[TBL] [Abstract][Full Text] [Related]
22. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
23. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
Timmons S; Kloczewiak M; Hawiger J
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
[TBL] [Abstract][Full Text] [Related]
24. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
25. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
26. Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction.
Kloczewiak M; Timmons S; Hawiger J
Thromb Res; 1983 Jan; 29(2):249-55. PubMed ID: 6302942
[TBL] [Abstract][Full Text] [Related]
27. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism.
Hantgan RR
Biochim Biophys Acta; 1988 Jan; 968(1):24-35. PubMed ID: 2827786
[TBL] [Abstract][Full Text] [Related]
28. Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain.
Kloczewiak M; Timmons S; Hawiger J
Biochem Biophys Res Commun; 1982 Jul; 107(1):181-7. PubMed ID: 6289817
[No Abstract] [Full Text] [Related]
29. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
[TBL] [Abstract][Full Text] [Related]
31. The interaction of fibrinogen with human platelets in a plasma milieu.
Marguerie GA; Thomas-Maison N; Larrieu MJ; Plow EF
Blood; 1982 Jan; 59(1):91-5. PubMed ID: 6274453
[TBL] [Abstract][Full Text] [Related]
32. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.
Niewiarowski S; Budzynski AZ; Morinelli TA; Brudzynski TM; Stewart GJ
J Biol Chem; 1981 Jan; 256(2):917-25. PubMed ID: 6256372
[No Abstract] [Full Text] [Related]
33. Inhibition of fibrin-platelet interactions by fibrinogen-degradation fragment D.
Orloff KG; Michaeli D
Am J Physiol; 1977 Aug; 233(2):H305-11. PubMed ID: 888974
[TBL] [Abstract][Full Text] [Related]
34. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.
McEver RP; Bennett EM; Martin MN
J Biol Chem; 1983 Apr; 258(8):5269-75. PubMed ID: 6220015
[TBL] [Abstract][Full Text] [Related]
35. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
[TBL] [Abstract][Full Text] [Related]
36. Interaction of fibrinogen with its platelet receptor: kinetics and effect of pH and temperature.
Marguerie GA; Plow EF
Biochemistry; 1981 Mar; 20(5):1074-80. PubMed ID: 6261783
[No Abstract] [Full Text] [Related]
37. Identification of a monoclonal antibody against platelet GPIIb that interacts with a calcium-binding site and induces aggregation.
Gulino D; Ryckewaert JJ; Andrieux A; Rabiet MJ; Marguerie G
J Biol Chem; 1990 Jun; 265(16):9575-81. PubMed ID: 1693151
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of collagen-induced fibrinogen binding to human platelets.
Legrand C; Dubernard V; Nurden AT
Biochim Biophys Acta; 1985 Feb; 812(3):802-10. PubMed ID: 3970909
[TBL] [Abstract][Full Text] [Related]
39. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
[No Abstract] [Full Text] [Related]
40. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain.
Kloczewiak M; Timmons S; Lukas TJ; Hawiger J
Biochemistry; 1984 Apr; 23(8):1767-74. PubMed ID: 6326808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
